Loss of PTEN Expression in Breast Cancers
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : PTEN, located on chromosome 10q23.31, is a novel tumor suppressor gene. In the sporadic breast cancers, the incidence of the loss of heterozygosity of PTEN is approximately 10% to 40%, but the incidence of intragenic mutation of PTEN is less than 1%. To assess the role of the PTEN in the invasive ductal breast cancer, we studied the frequency of the loss of PTEN expression, its correlation with the commonly used prognostic factors of the breast cancer and with PTEN promoter hypermethylation status. Methods : Immunohistochemical staining with an anti-PTEN protein antibody was performed on the paraffin-embedded breast tissues from 129 women with a diagnosis of invasive ductal carcinoma. Methylation specific PCR was performed to detect hypermethylation in the PTEN gene on the 28 cases with the loss of PTEN expression. Results : Sixty-two (48%) of 129 breast tumors had the loss of PTEN expression. The loss of PTEN expression was correlated with lymph node metastasis and stage, and there was a near-significant correlation with the tumor size. PTEN promoter hypermethylation was found in five (18%) out of 28 patients. Conclusion : These results suggest that the loss of PTEN expression might play a role in the progression of the breast cancer and that the aberrant promoter methylation is one of the silencing mechanisms of PTEN.
참고문헌 (23)
- "a putative protein tyrosine phosphatasegene mutated in human brain"
- "Tumor suppressor PTENinhibition of cell invasion,migration,and growth:differential involvementof focal adhesion kinase and p130Cas", 59, pp.442~9 (1999)
- "New insights into tumor suppression:PTENsuppresses tumor formation by restraining the phosphoinositide3-kinase", AKT pathway, 1999, pp.96, 4240~5
- "Germline mutations of the PTEN genein Cowden disease,an inherited breast and thyroid cancer syndrome", 16, pp.64~7 (1997), Nat Genet
- "Frequent inactivation ofPTEN", MMAC1 in primary prostate cancer, 1997, pp.57, 4997~5000
- "Identification of a candidatetumour suppressor gene 3that is mutated in multiple advanced cancers", 15, pp.356~62 (1997)
- "Mutations in PTEN are frequentin endometrial carcinoma but rare in other common gynecologicalmalignancies", 57, pp.3935~40 (1997)
- "Mutation analysis of the putative tumor suppressor gene PTEN", MMAC1 in primary breast carcinomas, 1997, pp.57, 3657~9
- "Allelic lossof chromosome 10q23 is associated with tumor progression in breast carcinomas", 17, pp.123~7 (1998)
- "Analysis of the 10q23chromosomal region and the PTEN gene in human sporadic breastcarcinoma", 79, pp.718~23 (1999)
- "Cancer as an epigenetic disease:DNAmethylation and chromatin alterations in human tumours", 196, pp.1~7
- "Methylation specific PCR:a novel PCR assay for methylation status ofCpG islands", 93, pp.9821~6 (1996)
- "Loss of expression of thePTEN gene protein product is associated with poor outcome inbreast cancer", 14, pp.672~6 (2001)
- "Immunohistochemical evidenceof loss of PTEN expression in primary ductal adenocarcinomasof the breast", 155, pp.1253~60 (1999)
- "Apoptosisrelated protein expressions in immunohistochemical stainingusing tissue microarrays of breast cancer", 60, pp.606~11 (2001)
- "Loss of expression of the PTENgene product in the infiltrating ductal carcinoma of the breastand its relationship with clinicopathologic factors", pp.600~5
- "Reduced expression of PTEN correlates with breast cancerprogression", 33, pp.405~9 (2002)
- "Loss of PTEN expression in paraffin-embedded primaryprostate cancer correlates with high Gleason score and advancedstage", 59, pp.4291~6 (1999)
- "PTEN gene mutationsare seen in high-grade but not in low-grade gliomas", 57, pp.4187~90 (1997)
- "PTEN methylation isassociated with advanced stage and microsatellite instability inendometrial carcinoma", 91, pp.22~6 (2001)
- "Promoter methylation and silencingof PTEN in gastric carcinoma", 82, pp.285~91 (2002)
- "Lack of PTEN expression in nonsmallcell lung cancer could be related to promoter methylation", 8, pp.1178~84 (2002), Clin Cancer Res
- "Inactivation of the tumor suppressorPTEN", MMAC1 in advanced human prostate cancerthrough loss of expression, 1998, pp.95, 5246~50